<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1679">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on October 07, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04273321</url>
  </required_header>
  <id_info>
    <org_study_id>Methylprednisolone in COVID-19</org_study_id>
    <nct_id>NCT04273321</nct_id>
  </id_info>
  <brief_title>Efficacy and Safety of Corticosteroids in COVID-19</brief_title>
  <official_title>Efficacy and Safety of Corticosteroids in COVID-19: A Prospective Randomized Controlled Trails</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Beijing Chao Yang Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Beijing Chao Yang Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      There is still controversy about the effective of glucocorticoids for the treatment of novel
      coronavirus pneumonia. This is a prospective randomized controlled trails. The aim is to
      explore the effectiveness and safety of glucocorticoids in the treatment of novel coronavirus
      pneumonia.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 14, 2020</start_date>
  <completion_date type="Actual">April 15, 2020</completion_date>
  <primary_completion_date type="Actual">April 15, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>the incidence of treatment failure in 14 days</measure>
    <time_frame>14 days</time_frame>
    <description>The clinical symptoms and signs continue to deteriorate, or new pulmonary or extrapulmonary lesions appear, or the chest imaging indicates the progress, and the patient is transferred to ICU or intubation and invasive ventilation or died.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>clinical cure incidence in 14 days</measure>
    <time_frame>14 days</time_frame>
    <description>The clinical symptoms and signs improved or alleviated (the temperature be normal , respiratory symptoms improved significantly, imaging showed obvious absorption) and no additional or alternative treatment was needed.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>the duration of virus change to negative</measure>
    <time_frame>30 days</time_frame>
    <description>the duration from admission to virus negative</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>mortality at day 30</measure>
    <time_frame>30 days</time_frame>
    <description>the patient die in 30 days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ICU admission rate in 30 days</measure>
    <time_frame>30 days</time_frame>
    <description>the patients transform to ICU because of clinical deteriorate in 30 days</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">86</enrollment>
  <condition>COVID-19</condition>
  <condition>Novel Coronavirus Pneumonia</condition>
  <arm_group>
    <arm_group_label>MP group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Con group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Methylprednisolone</intervention_name>
    <description>Methylprednisolone 1mg/kg/day ivgtt for 7 days.</description>
    <arm_group_label>MP group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age more than 18 years old

          -  accord with the clinical diagnosis and/ or etiological diagnosis diagnostic criteria
             of Novel coronavirus pneumonia (COVID-19).

          -  admitted in the general wards

          -  be able to sign informed consent

        Exclusion Criteria:

          -  severe immunosuppression (HIV infection, long-term use of immunosuppressive agents

          -  pregnant or lactation period women

          -  glucocorticoids are needed for other diseases

          -  unwilling or unable to participate or complete the study

          -  participate in other study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Hubei province hospital of integrated Chinese &amp; Western Medicine</name>
      <address>
        <city>Wuhan</city>
        <state>Hubei</state>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Yichang first people's Hospital</name>
      <address>
        <city>Yichang</city>
        <state>Hubei</state>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Beijing YouAn Hospital</name>
      <address>
        <city>Beijing</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Renmin Hospital of Wuhan University</name>
      <address>
        <city>Wuhan</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tianyou Hospital Affiliated to Wuhan University of science and technology</name>
      <address>
        <city>Wuhan</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Union Hospital Affiliated to Tongji Medical College of Huazhong University of science and technology</name>
      <address>
        <city>Wuhan</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>the first peopel hospital of Xiangyang</name>
      <address>
        <city>Xiangyang</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>February 15, 2020</study_first_submitted>
  <study_first_submitted_qc>February 17, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 18, 2020</study_first_posted>
  <last_update_submitted>May 8, 2020</last_update_submitted>
  <last_update_submitted_qc>May 8, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 11, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Beijing Chao Yang Hospital</investigator_affiliation>
    <investigator_full_name>Shi Huanzhong</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pneumonia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Methylprednisolone</mesh_term>
    <mesh_term>Methylprednisolone Acetate</mesh_term>
    <mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
    <mesh_term>Prednisolone</mesh_term>
    <mesh_term>Prednisolone acetate</mesh_term>
    <mesh_term>Prednisolone hemisuccinate</mesh_term>
    <mesh_term>Prednisolone phosphate</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

